The management of tremor

Neurology in Practice

Volumn 72, Issue 1, 2002, Pages

  Bain, Peter G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PHENOBARBITAL; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; BOTULINUM TOXIN A;

BRAIN DEPTH STIMULATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DYSTONIA; ELECTROMYOGRAM; ESSENTIAL TREMOR; HUMAN; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STEREOTAXIC SURGERY; TREMOR; BRAIN; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ELECTROSTIMULATION THERAPY; PROGNOSIS; SURGERY;

BOTULINUM TOXINS, TYPE A; BRAIN; CHOLINERGIC ANTAGONISTS; CLONAZEPAM; DIAGNOSIS, DIFFERENTIAL; ELECTRIC STIMULATION THERAPY; HUMANS; PRIMIDONE; PROGNOSIS; PROPRANOLOL; TREMOR;

EID: 0036188281     PISSN: 14737086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Deuschl G, Bain PG, Brin M, and an Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998;13:2-23.
2. Bain P. A combined clinical and neurophysiological approach to the study of patients with tremor. J Neurol Neurosurg Psychiatry 1993;56:839-44.
3. Bain PG. The clinical measurement of tremor. Mov Disord 1998;13(suppl 3):77-80.
4. Bain PG, Findley LJ, Atchison P, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry 1993;56:868-873.
5. Alusi SH, Worthington J, Findley U, et al. Evaluation of three different ways of assessing tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:756-60.
6. Boecker H, Brooks DJ. Functional imaging of tremor. Mov Disord 1998;13(suppl 3):64-72.
7. Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [I-123]-FP-CIT SPECT imaging. The [I-123]-FP-CIT study group. Mov Disord 2000;15:503-10.
8. McAuley JH, Britton TC, Rothwell JC, et al. The timing of primary orthostatic tremor bursts has task-specific plasticity. Brain 2000;123:254-66.
9. Marsden CD. Origins of normal and pathological tremor. In: Findley U, Capildeo R, eds. Movement disorders: tremor. London: Macmillan Press, 1987:37-84.
10. Shahani BT, Young RR. Physiological and pharmacological aids in the differential diagnosis of tremor. J Neurol Neurosurg Psychiatry 1976;39:772-83.
11. Bain PG, Findley U. Clinical aspects of parkinsonian tremor. In: NP Quinn, G Stern, eds. The Parkinson papers. London: Franklin Scientific Projects, 1992.
12. Louis ED, Ottman R, Hauser A. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 1998;13:5-10.
13. Gulcher JR, Jansson P, Kong A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nature Genet 1997;17:84-7.
14. Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord 1997;12:859-64.
15. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain 1994;117:805-24.
16. Rothwell JC, Traub MM, Marsden CD. Primary writing tremor. J Neurol Neurosurg Psychiatry 1979;42:1106-14.
17. Bain PG, Findley LJ, Britton TC, et al. Primary writing tremor. Brain 1995;118:1461-72.
18. Bain PG, Jenkins IH, Britton TC, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119:789-99.
19. Brooks DJ, Jenkins IH, Bain PG, et al. A comparison of the abnormal patterns of cerebral activation associated with neuropathic and essential tremor. Neurology 1992;42(suppl 3):423.
20. Holmes G. On certain tremors in organic cerebral lesions. Brain 1904;27:360-75.
21. Findley U, Gresty MA. Suppression of "rubral" tremor with levodopa. BMJ 1981;281:1043.
22. Alusi SH, Glickman S, Aziz TZ, et al. Tremor in multiple sclerosis. J Neurology Neurosurg Psychiatry 1999;66:131-4.
23. Alusi S, Glickman S, Worthington J, et al. A study of tremor in multiple sclerosis. Brain 2001;124:720-30.
24. Alusi SH, Aziz TZ, Glickman, et al. Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis. A prospective case-controlled study. Brain 2001;124:1576-89.
25. Holmes G. The cerebellum of man. Brain 1939;62:2-30.
26. Brown P, Rothwell JC, Stevens JM, et al. Cerebellar axial postural tremor. Mov Disord 1997;12:977-84.
27. McAuley JH, Rothwell JC, Marsden CD, et al. Electrophysiological aids in distinguishing organic from psychogenic tremor. Neurology 1998;50:1882-4.
28. Bain PG. The effectiveness of treatments for essential tremor. The Neurologist 1997;3:305-21.
29. Le Witt PA, Oertel WH, eds. Parkinson's disease: the treatment options. London: Martin Dunitz, 1999.
30. Pogarell O, Kunig G, Oertel WH. A non-ergot dopamine agonist, pramipexole, in the therapy of advanced Parkinson's disease: improvement of Parkinsonian symptoms and treatment associated complications. A review of three studies. Clin Neuropharmacol 1997;20(suppl 1):28-35.
31. Goldman MS, Kelly PJ. The surgical treatment of tremor disorders. In: Findley LJ, Koller WC, eds. Handbook of tremor disorders. New York: Marcel Dekker 1995:521-62.
32. Deep Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
33. Schuurman PR, Andries Bosch DA, Bossuyt PMM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461-8.